Clinical

SASKATOON | New vaccine research and development against existing and emerging diseases can now proceed thanks to final certification of the Vaccine and Infectious Disease Organization’s International Vaccine Centre at the University of Saskatchewan.

Scientists report dramatic breakthrough in treating virus.

TORONTO | The Ontario Institute for Cancer Research is collaborating with pharmaceutical company Janssen to find and test new biomarkers to identify patients with hormone-resistant prostate cancer at high risk for disease progression and biomarkers of response to therapy.

MONTREAL | Laurent Pharmaceuticals, a start-up pharmaceutical company specializing in drug development for orphan diseases, has been created by MSBi Valorisation, McGill University and the Research Institute of the McGill University Health Centre.

Safety trial of MRI-guided ultrasound ablation launched in Ontario

Rest remains the cornerstone of management, but new advice is ‘more relaxed’